Published in Am J Gastroenterol on January 01, 1999
Effects of nitric oxide inhibition by methylene blue in cirrhotic patients with ascites. Dig Dis Sci (2005) 1.38
Tumor necrosis factor-alpha, interleukin-6, and nitric oxide in sterile ascitic fluid and serum from patients with cirrhosis who subsequently develop ascitic fluid infection. Dig Dis Sci (2001) 1.13
Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma. World J Gastroenterol (2006) 1.07
Increased tumour necrosis factor alpha production in mesenteric lymph nodes of cirrhotic patients with ascites. Gut (2003) 0.88
Physiopathology of splanchnic vasodilation in portal hypertension. World J Hepatol (2010) 0.87
Effect of L-NAME on nitric oxide and gastrointestinal motility alterations in cirrhotic rats. World J Gastroenterol (2002) 0.86
Serum levels of soluble Fas, nitric oxide and cytokines in acute decompensated cirrhotic patients. World J Gastroenterol (2007) 0.85
Decreased heart rate variability in patients with cirrhosis relates to the presence and degree of hepatic encephalopathy. Am J Physiol Gastrointest Liver Physiol (2008) 0.84
Bedside sublingual video imaging of microcirculation in assessing bacterial infection in cirrhosis. Dig Dis Sci (2009) 0.84
Increased intestinal macromolecular permeability and urine nitrite excretion associated with liver cirrhosis with ascites. World J Gastroenterol (2008) 0.83
Trichostatin A Protects Against Experimental Acute-on-Chronic Liver Failure in Rats Through Regulating the Acetylation of Nuclear Factor-κB. Inflammation (2015) 0.82
Detecting minimal hepatic encephalopathy in an endemic country for hepatitis B: the role of psychometrics and serum IL-6. PLoS One (2015) 0.80
MELD score, insulin-like growth factor 1 and cytokines on bone density in end-stage liver disease. World J Hepatol (2011) 0.80
Liver Failure Impairs the Intrahepatic Elimination of Interleukin-6, Tumor Necrosis Factor-Alpha, Hepatocyte Growth Factor, and Transforming Growth Factor-Beta. Biomed Res Int (2015) 0.78
Lentiviral vector-mediated down-regulation of IL-17A receptor in hepatic stellate cells results in decreased secretion of IL-6. World J Gastroenterol (2012) 0.77
Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis. Dig Dis Sci (2016) 0.75
Modulation of inflammatory response in a cirrhotic rat model with induced bacterial peritonitis. PLoS One (2013) 0.75
Severity of Systemic Inflammatory Response Syndrome Affects Outcomes in Decompensated Cirrhotics with Spontaneous Bacterial Peritonitis. Am J Gastroenterol (2016) 0.75
Soluble interleukin-6 receptor levels in liver cirrhosis. Am J Gastroenterol (1999) 0.75
Probiotics for the hemodynamic alterations of patients with liver cirrhosis. Am J Gastroenterol (2000) 0.75
Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol (1992) 6.09
Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. Am J Trop Med Hyg (2001) 4.32
Epidemic leptospirosis associated with pulmonary hemorrhage-Nicaragua, 1995. J Infect Dis (1998) 3.97
Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study. Hum Mol Genet (1999) 3.93
High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA. J Clin Microbiol (1999) 3.88
Hepatitis C virus antibodies among risk groups in Spain. Lancet (1989) 3.66
Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med (1996) 3.60
Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA. Proc Natl Acad Sci U S A (1988) 3.23
Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet (1999) 3.14
New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci U S A (1998) 3.14
The Washington Heights-Inwood Genetic Study of Essential Tremor: methodologic issues in essential-tremor research. Neuroepidemiology (1997) 2.96
Linkage detection by the Affected-Pedigree-Member method: what is really tested? Genet Epidemiol (1993) 2.88
Survey of moonlighting practices and work requirements of emergency medicine residents. Am J Emerg Med (2000) 2.78
Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science (1982) 2.68
Cysticercosis as a major cause of epilepsy in Peru. The Cysticercosis Working Group in Peru (CWG) Lancet (1993) 2.66
Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru. Neurology (1997) 2.60
Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc Natl Acad Sci U S A (1996) 2.53
Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med (1990) 2.50
Are Himalayan Sherpas better protected against brain damage associated with extreme altitude climbs? Clin Sci (Lond) (1996) 2.48
The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J Hepatol (2001) 2.42
Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39
Atmospheric oxidation capacity sustained by a tropical forest. Nature (2008) 2.34
Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge. J Infect Dis (2000) 2.29
Reasons for dissatisfaction: a survey of relatives of intensive care patients who died. Crit Care Med (1998) 2.20
Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology (1985) 2.09
Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease. Vaccine (1995) 2.06
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*. J Viral Hepat (2011) 2.00
Portable encapsidation signal of the L-A double-stranded RNA virus of S. cerevisiae. Cell (1990) 2.00
Lest we forget: neuropsychiatry and the new generation anti-HIV drugs. AIDS (1998) 2.00
Genetic influences on the end-stage effector phase of arthritis. J Exp Med (2001) 1.99
Brain tumor and pregnancy. Obstet Gynecol (1997) 1.97
Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding. N Engl J Med (2000) 1.96
Excimer laser ablation of the human lens at 308 nm with a fiber delivery system. J Cataract Refract Surg (1989) 1.92
Dermatologic consultations in the hospital setting. Arch Dermatol (1994) 1.91
The role of CD8+ T cells in the initiation of insulin-dependent diabetes mellitus. Eur J Immunol (1996) 1.87
Genetic mapping of the Gs-alpha subunit gene (GNAS1) to the distal long arm of chromosome 20 using a polymorphism detected by denaturing gradient gel electrophoresis. Genomics (1991) 1.84
Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr (1995) 1.81
Incidence of inflammatory bowel disease in northern France (1988-1990). Gut (1994) 1.81
Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients. Am J Nephrol (1992) 1.77
Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology (1998) 1.74
In vitro L-A double-stranded RNA synthesis in virus-like particles from Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1986) 1.74
Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy. Arch Intern Med (1998) 1.70
Viral genotype and baseline load predict the response to adefovir treatment in lamivudine-resistant chronic hepatitis B patients. J Hepatol (2007) 1.68
First pass metabolism of ethanol is strikingly influenced by the speed of gastric emptying. Gut (1998) 1.68
Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension. Hepatology (1983) 1.67
Sorting and endocytosis of viral glycoproteins in transfected polarized epithelial cells. J Cell Biol (1986) 1.66
Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut (2005) 1.65
Minichromosomal repetitive DNA in Trypanosoma cruzi: its use in a high-sensitivity parasite detection assay. Proc Natl Acad Sci U S A (1984) 1.65
Apparent generation of a segmented mRNA from two separate tandem gene families in Trypanosoma cruzi. Nucleic Acids Res (1985) 1.64
Diagnosis of cysticercosis in endemic regions. The Cysticercosis Working Group in Peru. Lancet (1991) 1.63
Negative, psychoticism, and disorganized dimensions in patients with familial schizophrenia or bipolar disorder: continuity and discontinuity between the major psychoses. Am J Psychiatry (1995) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells. Cancer Res (1999) 1.59
Posterior probability of linkage and maximal lod score. Ann Hum Genet (1995) 1.58
Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat. Gastroenterology (1999) 1.58
Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology (1994) 1.56
Association of participation in a mindfulness programme with bowel symptoms, gastrointestinal symptom-specific anxiety and quality of life. Aliment Pharmacol Ther (2011) 1.54
Cost-effectiveness of combination therapy for naive patients with chronic hepatitis C. J Hepatol (2000) 1.53
Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study. Ann Rheum Dis (2010) 1.53
Vasodilatation and sodium retention in prehepatic portal hypertension. Gastroenterology (1992) 1.53
Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. Proc Natl Acad Sci U S A (1997) 1.52
Wedged and free hepatic venous pressure measured with a balloon catheter. Gastroenterology (1979) 1.52
Measurement of portal-systemic shunting in the rat by using gamma-labeled microspheres. Am J Physiol (1981) 1.50
Clinical approach to inherited peroxisomal disorders: a series of 27 patients. Ann Neurol (1998) 1.49
Reporting ethics committee approval and patient consent by study design in five general medical journals. J Med Ethics (2006) 1.47
Three different M1 RNA-containing viruslike particle types in Saccharomyces cerevisiae: in vitro M1 double-stranded RNA synthesis. Mol Cell Biol (1986) 1.47
Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology (1998) 1.47
Sinus venosus syndrome: atrial septal defect or anomalous venous connection? A multiplane transoesophageal approach. Heart (2002) 1.47
Perception of sweet taste is important for voluntary alcohol consumption in mice. Genes Brain Behav (2007) 1.46
Evaluation of recombinant antigens for serodiagnosis of Chagas' disease in South and Central America. J Clin Microbiol (1999) 1.45
NADP-glutamate dehydrogenase isoenzymes of Saccharomyces cerevisiae. Purification, kinetic properties, and physiological roles. J Biol Chem (2001) 1.45
Distal splenorenal vs. portal-systemic shunts after hemorrhage from varices: a randomized controlled trial. Hepatology (1988) 1.45
Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disorders. Hepatology (2001) 1.45
Ca2+ sparks and embers of mammalian muscle. Properties of the sources. J Gen Physiol (2003) 1.45
Patterns of cocaine binging: effect on pregnancy. Am J Obstet Gynecol (1994) 1.44
Evidence of a cohort effect for age at onset of schizophrenia. Am J Psychiatry (2001) 1.44
Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. Genomics (1997) 1.44
Type III radical hysterectomy after induction chemotherapy for patients with locally advanced cervical carcinoma. Int J Gynecol Cancer (2001) 1.43
Biosynthesis and intracellular sorting of growth hormone-viral envelope glycoprotein hybrids. J Cell Biol (1985) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology (2001) 1.41
Genetic mapping of common diseases: the challenges of manic-depressive illness and schizophrenia. Trends Genet (1990) 1.41
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
[Diagnostic and therapeutic management of patients with chronic inflammatory bowel disease]. Rev Epidemiol Sante Publique (1999) 1.39
New absorbable synthetic explants for the treatment of retinal detachment. Retina (1987) 1.39
A multicenter, randomized, double-blind study comparing once-daily bedtime administration of famotidine and ranitidine in the short-term treatment of active duodenal ulcer. Hepatogastroenterology (1989) 1.39
Viremia and nasal and rectal shedding of rotavirus in gnotobiotic pigs inoculated with Wa human rotavirus. J Virol (2005) 1.38
European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology (1999) 1.38
[Hepatocellular carcinoma: clinical aspects, diagnosis, and survival in 140 cases]. Med Clin (Barc) (1993) 1.38
[One year treatment with lamivudine in different hepatitis B virus related hepatic diseases]. Gastroenterol Hepatol (1999) 1.38